Latest News and Press Releases

ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...

Boehringer and Re-Vana enter strategic collaboration to develop extended-release eye therapies, aiming to reduce injections and improve patient outcomes.

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on...

ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and...

Chicago, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The modern causes of blurry vision and digital eye fatigue, including screen exposure and poor nutritionWhy traditional...

New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The real reasons why so many people today experience blurry vision, digital eye strain, and age-related eyesight...

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The hidden causes behind the sharp rise in vision problems in 2025How digital screens, pollution, and aging...

SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- The Glaucoma Research Foundation (GRF) is launching a national awareness campaign, “Your Eyes Say Thanks,” to educate the public on the importance...

The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event.